Measles immunization with killed virus vaccine: Serum antibody titers and experience with exposure to measles epidemic

Bulletin of the World Health Organization

Volumn 78, Issue 2, 2000, Pages 226-231

  Rauh, Louise W ^a,b   Schmidt, Rosemary ^a  

^a Babies Milk Fund Assoc Matern Soc   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; MALE; MEASLES; MEASLES VACCINATION; NORMAL HUMAN; TREATMENT OUTCOME;

EID: 0034071209     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Guinee, V. F.: Amer J Public Health 53:645 (April) 1963.
2. Fulginiti, V. A., and Kempe, C. H.: Amer J Dis Child 106:450 (Nov) 1963.
3. Winkelstein, W., Jr., et al: JAMA 179:398 (Feb 10) 1962.
4. Karelitz, S., et al: JAMA 184:673 (June) 1963.
5. Karzon, D. T., et al: Amer J Dis Child 103:425 (March) 1962.
6. Enders, J. F.; Katz, S. L.; and Holloway, A.: Amer J Dis Child 103:165 (March) 1962.
7. Warren, J.; Crawford, J. G.; and Gallian, M. J.: Amer J Dis Child 103:452 (March) 1962.
8. Terry, L. L.: Status of Measles Vaccines: Technical Report - Surgeon General, Public Health Service US Department of Health, Education & Welfare, 1963.
9. Ad Hoc Advisory Committee on Measles Control: JAMA 183:1112-1113 (March 30) 1963.